Autres langues Lineage Cell Therapeutics, Inc.

Actions

LCTX

US53566P1093

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 20:12:28 27/08/2026			Varia. 5j.	Varia. 1 janv.
1,145 ^USD	+2,23%		+6,02%	-31,44%

07/08	Transcript : Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026
06/08	Lineage Cell Therapeutics, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

06/08	Lineage Cell: Q2 Earnings Snapshot
06/08	Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
06/08	Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
30/07	Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
13/07	Lineage Cell Therapeutics Provides Update On COR1 Cell Therapy Program For Corneal Endothelial Disease
13/07	Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
06/07	Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell Small Cap Comp Growth Benchmark
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2000 Index
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2500 Growth Benchmark
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2000 Growth Benchmark
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 3000E Index
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 3000E Growth Benchmark
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2000 Dynamic Index
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell Microcap Growth Benchmark Index
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell Microcap Index
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell Small Cap Completeness Index
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 3000 Growth Benchmark
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2500 Index
29/06	Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 3000 Index
20/05	Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
12/05	Lineage Cell Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
12/05	Lineage Cell: Q1 Earnings Snapshot
12/05	Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
05/05	Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026